Back to CAPRView Full Landscape
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
10 competitors in Duchenne Muscular Dystrophy
BMYCapricor Duchenne cell therapy
CAPCderamiocel
RGNXRGX-202
RHHBYRO7239361
Phase 3SRPTEteplirsen
Phase 3Drug Information
Target Indication
Duchenne Muscular Dystrophy
Mechanism of Action
Cell Therapy
Clinical Trial
NCT05126758Last updated: 12/3/2025
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts